Bacteriophage-based particle carrying TNF-related apoptosis-inducing ligand (TRAIL) gene for targeted delivery to Hepatocellular carcinoma
Pattaralawan Sittiju,Benjawan Wudtiwai,Aitthiphon Chongchai,Amin Hajitou,Prachya Kongtawelert,Peraphan Pothacharoen,Keittisak Suwan
DOI: https://doi.org/10.1039/d3nr05660k
IF: 6.7
2024-02-24
Nanoscale
Abstract:TRAIL (Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand) is a promising candidate for cancer treatment due to its unique ability to selectively induce programmed cell death, or apoptosis, in cancer cells while sparing healthy ones. This selectivity arises from TRAIL's preferential binding to death receptors on cancer cells, triggering a cascade of events that lead to their demise. However, significant limitations in using TRAIL for cancer treatment is administration of TRAIL protein that can potentially lead to tissue toxicity (off-target), the short half-life of TRAIL in the body may necessitate frequent and sustained administration, which can pose logistical challenges for long-term treatment regimens. We have devised a novel approach to surmount these limitations by introducing the TRAIL gene directly into cancer cells, enabling them to produce TRAIL locally and subsequently trigger apoptosis. A novel gene delivery system, a bacteriophage-based particle TPA (transmorphic phage/AAV) was utilized to address these limitations. TPA is a hybrid M13 filamentous bacteriophage particle encapsulating therapeutic gene cassette with inverted terminal repeats (ITR) from adeno-associated virus (AAV). The particle also displayed a tumour targeting ligand, CDCRGDCFC (RGD4C), on its capsid (RGD4C.TPA) to target the particle to cancer cells. The RGD4C selectively binds to αvβ3 and αvβ5 integrins overexpressed on the surface of most of cancer cells but barely present on normal cells. Hepatocellular carcinoma (HCC) was chosen as a model because it has one of the lowest survival rates among cancers. We demonstrated that human HCC cell lines (Huh-7 and HepG2) expresses αvβ5 integrins receptors on their surface. These HCC cells also express death receptors, TRAIL binding receptors. We showed that targeted TPA particle carrying transmembrane TRAIL gene (RGD4C.TPA-tmTRAIL) selectively and efficiently delivered tmTRAIL gene to HCC cells resulting in production of tmTRAIL from transduced cells and subsequently induced apoptotic death of HCC cells. This tumour-targeted particle can be an excellent candidate for targeted gene therapy of HCC.
materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology,chemistry